Background: Hereditary defects of tooth dentin are classified into two main groups: dentin dysplasia (DD) (types I and II) and dentinogenesis imperfecta (DGI) (types I, II, and III). Type II DGI is one of the most common tooth defects with an autosomal dominant mode of inheritance. One disease-causing gene, the dentin sialophosphoprotein (DSPP) gene, has been reported for type II DGI.
Background
Hereditary defects of tooth dentin include two types of dentin dysplasia (DDI and DDII) and three types of dentinogenesis imperfecta (DGII, II and III). Dentinogenesis imperfecta (DGI) is an autosomal dominant disorder characterized by discolored teeth and often dislodged enamel due to abnormal mineralization of the dentine of the primary teeth [1, 2] . The population prevalence rate of DGI is estimated to be 1 in 6,000 to 8,000 individuals [3] . Type I DGI is the least severe and type III is the most severe [1] . Type I DGI is associated with osteogenesis imperfecta, whereas type II DGI and type III DGI are restricted to the dentin.
To date, only one disease-causing gene, DSPP encoding the dentin sialophosphoprotein, has been identified for DGI [4] . The DSPP gene is located on human chromosome 4q21.3 and transcribed into one transcript which is translated into the DSPP precursor protein [4] . The precursor is cleaved to form two mature proteins, dentin sialoprotein (DSP) and dentin phosphoprotein (DPP). DSP and DPP are the major non-collagenous proteins of dentin expressed in teeth and bone [4] . DPP is rich in aspartic acid and phosphoserine and binds to a large amount of calcium. DSP is a glycoprotein rich in aspartic acid, serine, glutamic acid and glycine [4] [5] [6] [7] . Yamakoshi et al. has established that DSP is a proteoglycan, and identified a third domain, the dentin glycoprotein (DGP) domain of DSPP [8, 9] .
The discovery of DSPP as the gene for type II DGI was made in 2001 [10, 11] . Several mutations have been reported in DSPP. These mutations include five missense mutations (p.Y6D, p.A15V, p.P17T, p.V18F, and p.R68W), one nonsense mutation (p.Q45X), and three splicing mutations (g.1188C→G; g.1275G→A; g.1194C>A (IVS2-3)) [10] [11] [12] [13] [14] [15] [16] . Mutation p.Y6D was found to be associated with type II dentin dysplasia (DD) [17] , this mutation is located in the signal peptide domain of DSPP, and disabled the entry of DSPP into the endoplasmic reticulum [17] . Mutation p.V18F can cause both type II and type III DGI. Mutation carriers with p.P17V and p.V18F also presented with progressive sensorineural high-frequency hearing loss [11] . The remaining mutations described above cause type II DGI. One DSPP mutation was found in a family with type III DGI (a compound mutation consisting of a 36 bp deletion and 18 bp insertion in exon 5) [18] .
In this study, we identified and characterized a four-generation Chinese family with type II DGI with 18 living family members and 8 affected individuals. We used linkage analysis to map the disease-causing gene in the family to the DSPP gene on chromosome 4q21.3, and further studies identified a novel mutation (c. 49C>T, p.Pro17Ser) in DSPP in the family. Our finding suggests that Pro17 is a mutational hotspot and it may be critical for the function of DSPP gene.
Methods
Study subjects and isolation of human genomic DNA The study participants were identified and enrolled at Luoyang Medical College. Detailed records on medical history, clinical and radiographic features were obtained. Informed written consent was obtained from the study subjects. This study was approved by the ethics committee of Huazhong University of Science and Technology. Peripheral blood was collected from the participants. Human genomic DNA was isolated from the whole blood using the DNA Isolation Kit for Mammalian Blood (Roche Diagnostic Co., Indianapolis, IN).
Linkage analysis
Two polymorphic microsatellite markers, D4S414 and D4S1534 linked to DSPP, were selected from the ABI PRISM Linkage Mapping Set-MD10 panel for linkage analysis. Markers were genotyped using an ABI 3100 Genetic Analyzer at Huazhong University of Science and Technology Center for Human Genome Research (Applied Biosystems, Foster City, CA). Genotypes were analyzed using the GeneMapper 2 Software program (Applied Biosystems, Foster City, CA).
Mutation screening
Mutation screening was carried out using direct DNA sequence analysis. All five DSPP exons including exonintron boundaries were PCR-amplified and sequenced. The PCR primers for amplification of the DSPP exons and exon-intron boundaries are: PCR was performed in 25 μl of standard PCR buffer containing 1.5 mM MgCl 2 , 0.2 mM of each dNTP, 0.5 μM of each primer, 1 unit of Taq DNA polymerase, and 25 ng of human genomic DNA. The amplification program was one cycle of 3 min for denaturation at 94°C, 35 cycles of 30 s at 94°C, 30 s at 65°C, 1 min at 72°C, and one 7 min extension step at 72°C. The PCR products were purified using the QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA), and sequenced with both forward and reverse primers. DNA sequencing analysis was performed using the BigDye Terminator Cycle Sequencing v3.1 kit and an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA).
RFLP (restriction fragment length polymorphism) analysis
Mutation c.49C>T(p.Pro17Ser) disrupts a Bsr I restriction site, which allowed us to perform RFLP analysis to confirm the mutation and to test whether the mutation cosegregates with the disease in the family. Exon 1 of DSPP containing the p.Pro17Ser mutation was PCR-amplified from members of the family as well as 100 unrelated healthy Chinese individuals. The 468 bp PCR product was digested with 1 unit of Bsr I restriction enzyme (New England Biolabs Inc, Ipswich, MA) at 65°C for overnight. The digested products were separated and analyzed on a 2.0% agarose gel.
Results
We identified a four-generation Chinese family with type II DGI with 18 living family members and 8 affected individuals. The proband was a 28-year-old female (III-1 in Fig. 1 ). At the age of 10-years, the enamel was lost through attrition. Similar clinical features were detected in other 7 affected family members. The oral radiographs of the affected son of the proband (IV:2 in Fig. 1 ) are shown in Fig. 2 .
To test whether the DSPP gene on chromosome 4q13-21 is the disease-causing gene in the family, we carried out linkage analysis with two markers that span the DSPP gene, D4S414 and D4S1534. As shown in Fig. 1 , allele 1 of D4S414 and allele 4 of D4S1534 co-segregate with the disease in the family. These results suggest that the disease gene in the family is the DSPP gene.
Direct DNA sequence analysis of the DNA from the proband revealed a heterozygous C→T transition at nucleotide 49 of DSPP, which results in a substitution of amino acid residue proline by a serine residue (Pro17Ser) (Fig. 3A) . The Pro17 residue of protein DSP is evolutionarily conserved in homo sapiens, rattus norvegicus, mus musculus, sus scrofa and bos taurus.
To confirm that the Pro17Ser mutation of DSPP is associated with the disease in the family, RFLP analysis was cara-b. Oral photographs from the affected individual (IV:2 in (Fig. 4) . RFLP analysis also showed that the p.Pro17Ser mutation was not present in normal family members (Fig. 4) and 100 normal controls (data not shown). These results provide strong genetic evidence that the pPro17Ser mutation of DSPP causes type II DGI in the Chinese family.
Discussion
In this study, we identified a novel mutation, c.49C>T(p.Pro17Ser), in the dentin sialophosphoprotein gene (DSPP) in a Chinese family affected with dentinogenesis imperfecta II (type II DGI). The p.Pro17Ser mutation co-segregated with only affected individuals, and did not exist in normal family members and 100 controls. The Pro17 residue is highly conserved during evolution. These results strongly suggest that the p.Pro17Ser mutation causes type II DGI.
Interestingly, the Pro17 residue was mutated to a threonine residue in a different DGI II family with five patients [11] . In contrast to the family in this study, the affected individuals with mutation p.Pro17Thr were also associated with bilateral progressive sensorineural high-frequency hearing loss [11] . Together with the study by Xiao et al., our study suggests that the Pro17 residue is a mutation hot-spot that is critical to the function of DSPP gene. Consistent with this conclusion, the Pro17 residue is conMutation Pro17Ser of the DSPP gene co-segregated with type II DGI in the family Figure 4 Mutation Pro17Ser of the DSPP gene co-segregated with type II DGI in the family. N, normal phenotype; P, affected phenotype; marker, molecular size standard. The lanes are labelled with the unique identification number for each individual in the Chinese family as in Fig. 1 The molecular mechanisms by which DSPP mutations cause DGI are not clear. Only one mutation, p.Y6D located in the proposed hydrophobic signal peptide domain, was biochemically characterized. Rajpar et al. showed that the p.Y6D mutation blocked translocation of the proteins encoded by DSPP into the endoplamic reticulum(ER), suggesting that it is a loss-of-function mutation [17] . The predicted signal peptide domain of DSP spans the first 15 amino acid residues (MKIITYFCIWAVA-WAIPVPQ). The Pro17 residue is only one amino acid residue away from the signal peptide, thus Xiao et al. proposed that the p.Pro17Thr mutation may interfere with signal peptide cleavage [11] . Similarly, the p.Pro17Ser mutation identified in this study may also affect signal peptide cleavage, which may lead to reduced translocation of DSPP to ER. One other possibility is that the p.Pro17Ser mutation may affect pre-mRNA splicing of DSPP as it is located at the exon 2/intron 2 boundary, and changes a highly conserved C/A to T at the position of -3 of the 5'-splicing donor site. On the other hand, as the Pro17 residue is the second amino acid residue in the mature DSP protein, it may directly affect the biological functions of DSP. These hypotheses remain to be tested with functional studies.
Knockout mice deficient in DSPP showed dentin defects that most closely resemble type III dentinogenesis imperfecta, which has more extreme abnormal dental phenotype that impacts beyond dentin to the enamele and the pulps of affected teeth [19] . The Dspp -/-mice displayed the phenotype of enlarged pulp chambers, increased width of predentin zone, hypomineralization, and pulp exposure [19] . Transgenic mice with over-expression of dentin sialoprotein and dentin phosphoprotein were created and characterized [6] . Mice with over-expression of dentin sialoprotein showed an increased rate of enamel mineralization. No significant defects in the enamel morphology were observed. Mice with over-expression of dentin phosphoprotein showed defects in enamel structure with "pitted" and "chalky" enamel of non-uniform thickness [6] . Thus, the knockout mice displayed the phenotype that more closely resemble human DGI than the transgenic overexpression mice, which supports the hypothesis that the DSPP mutations may act by a loss-of-function mechanism.
Conclusion
These results suggest that mutation p.Pro17Ser causes type II DGI in the Chinese family. This study identifies a novel mutation in the DSPP gene, and expands the spectrum of mutations that cause DGI.
